Insulin treatment, NIDDM and atherosclerosis.
Shumak
S L
SL
University of Calgary.
D001161:Arteriosclerosis / Q000209:etiology*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007328:Insulin / Q000009:adverse effects* / Q000627:therapeutic use; D011384:Proinsulin / Q000096:biosynthesis
D007328:Insulin; D011384:Proinsulin